Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 12-Nov-25 | 10057.30 | 0.57% | - | 0.08% | 65/240 |
| 1 Month | 17-Oct-25 | 10205.40 | 2.05% | - | 0.75% | 48/239 |
| 3 Month | 19-Aug-25 | 10269.90 | 2.70% | - | 2.82% | 128/235 |
| 6 Month | 19-May-25 | 10446.20 | 4.46% | - | 5.74% | 138/225 |
| YTD | 01-Jan-25 | 9677.70 | -3.22% | - | 4.47% | 180/212 |
| 1 Year | 19-Nov-24 | 10416.50 | 4.17% | 4.17% | 7.15% | 137/198 |
| 2 Year | 17-Nov-23 | 14224.90 | 42.25% | 19.18% | 18.01% | 62/154 |
| Since Inception | 14-Dec-22 | 17249.70 | 72.50% | 20.42% | 12.67% | 29/218 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 19-Nov-24 | 12000 | 12441.27 | 3.68 % | 6.85 % |
| 2 Year | 17-Nov-23 | 24000 | 26585.16 | 10.77 % | 10.14 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 201.4 | 22.18% | 0.57% | 25.51% (Apr 2025) | 21.61% (Sep 2025) | 1.19 L | -0.25 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 96.8 | 10.66% | 1.36% | 11.01% (May 2025) | 9.3% (Sep 2025) | 14.36 k | -27.00 |
| Cipla Ltd. | Pharmaceuticals | 95.5 | 10.51% | -0.37% | 11.42% (Aug 2025) | 10.2% (Dec 2024) | 63.59 k | -0.13 k |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.5 | 9.08% | -0.51% | 10.28% (Dec 2024) | 9.08% (Oct 2025) | 68.88 k | -0.14 k |
| Lupin Ltd. | Pharmaceuticals | 53.7 | 5.91% | -0.03% | 6.89% (Dec 2024) | 5.7% (Jul 2025) | 27.35 k | -56.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 42.1 | 4.64% | -0.21% | 4.85% (Sep 2025) | 3.83% (Dec 2024) | 11.83 k | -21.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 41.9 | 4.61% | 0.41% | 4.61% (Oct 2025) | 2.87% (Nov 2024) | 43.92 k | -89.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 36 | 3.97% | 0.07% | 4.55% (Nov 2024) | 3.67% (Aug 2025) | 31.62 k | -63.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 35.1 | 3.86% | -0.07% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 6.37 k | -9.00 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 32.2 | 3.55% | -0.24% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 17.03 k | -33.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.67% |
| Net Receivables | Net Receivables | -0.65% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | -1.10 | 10.41 | 43.44 | 40.35 | 33.75 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | -1.10 | 1.84 | 12.13 | 27.60 | 14.44 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 3.95 | 7.39 | 18.45 | 25.63 | 0.00 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.08 | 4.88 | 18.40 | 22.68 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.70 | 5.80 | 10.90 | 21.22 | 19.82 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | 0.24 | 7.23 | 16.27 | 21.10 | 11.87 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.65 | 7.41 | 8.67 | 21.00 | 13.66 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.44 | 5.90 | 7.09 | 20.99 | 0.00 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.20 | 6.67 | 8.94 | 20.04 | 17.56 |
| HDFC Banking and Financial Services Fund - Growth | NA | 4362.29 | 3.49 | 6.47 | 7.98 | 18.37 | 16.93 |
Out of 175 mutual fund schemes offered by this AMC, 10 is/are ranked 5 * , 8 is/are ranked 4 * , 15 is/are ranked 3 * , 5 is/are ranked 2 * , 2 is/are ranked 1 * , and 135 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Large Cap Fund - Growth | 5 | 75863.08 | 1.80 | 3.79 | 5.66 | 11.84 | 18.19 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 71900.48 | 0.55 | 5.66 | 7.68 | 16.12 | 19.40 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 71900.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ICICI Prudential Balanced Advantage Fund - Growth | 2 | 68449.94 | 0.92 | 3.53 | 5.91 | 11.79 | 13.60 |
| ICICI Prudential Value Fund - Growth | 5 | 57934.73 | 2.45 | 4.51 | 6.50 | 12.50 | 21.48 |
| ICICI Prudential Liquid Fund - Growth | 3 | 50120.55 | 0.49 | 1.43 | 2.96 | 6.60 | 6.97 |
| ICICI Prudential Equity & Debt Fund - Growth | 5 | 48071.30 | 0.87 | 3.76 | 5.97 | 13.39 | 19.33 |
| ICICI Prudential Money Market Fund - Growth | 4 | 35011.13 | 0.54 | 1.48 | 3.27 | 7.57 | 7.54 |
| ICICI Prudential Nifty 50 ETF | 5 | 34935.53 | 1.46 | 4.46 | 5.38 | 12.12 | 13.72 |
| ICICI Prudential Nifty 50 ETF | 5 | 34935.53 | 1.46 | 4.46 | 5.38 | 12.12 | 13.72 |